Skip to main content
Clinical Trials/IRCT2016111914901N9
IRCT2016111914901N9
Completed
Phase 2

Effect of macronutrient composition of the enteral diet on glycemic control in critically ill patients

ational Nutrition and Food Technology Research Institute0 sites48 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
critically ill patients.
Sponsor
ational Nutrition and Food Technology Research Institute
Enrollment
48
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Nutrition and Food Technology Research Institute

Eligibility Criteria

Inclusion Criteria

  • Adult patients in both sexes who will be hospitalized in ICU and initiating enteral nutrition within 48 hours following the hospital admission, will be included in this study. Patients enrolled in other studies that are pregnant or with previous diabetes, hyperglycemia on admission, Body Mass Index (BMI) \= 30 kg/m2, hyperlipidemia, liver failure, nephrotic syndrome and any contraindication to enteral nutrition, will be excluded. Patients who are discharge or die before the fifth day of enteral nutrition administration will be also excluded from the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials